Skip to content

electroCore, Inc. ECOR Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

ClearPoint Neuro logo
ClearPoint NeuroCLPT
$1.1M-15.4%
LivaNova logo
LivaNovaLIVN
$10.31M-10.2%
ITG
Integer HoldingsITGR
$600K+50.0%
Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: electroCore, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s allowance for doubtful accounts receivable (current)?
electroCore, Inc. (ECOR) reported allowance for doubtful accounts receivable (current) of $600K in Q4 2025.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.